Cargando…
What clinical trials of ablation for atrial fibrillation tell us – and what they do not
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in clinical practice. Radiofrequency and cryoballoon catheter ablation are therapeutic options in addition to antiarrhythmic drug therapy for the treatment of AF. Ablation is effective at reducing recurrent atrial arrhythmias and also...
Autores principales: | Amuthan, Ram, Curtis, Anne B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183809/ https://www.ncbi.nlm.nih.gov/pubmed/34113920 http://dx.doi.org/10.1016/j.hroo.2021.02.001 |
Ejemplares similares
-
From background to solutions: Eliminating sex gaps in clinical electrophysiology practice
por: Amuthan, Ram, et al.
Publicado: (2022) -
New hypoglycemic agents and the kidney: what do the major trials tell us?
por: Smyth, Brendan, et al.
Publicado: (2018) -
LFP and oscillations—what do they tell us?
por: Friston, Karl J, et al.
Publicado: (2015) -
Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet)
por: Casula, Manuela, et al.
Publicado: (2022) -
What do patents tell us about microalgae in agriculture?
por: Murata, Mayara Mari, et al.
Publicado: (2021)